213 POSTER Phase II multicenter trial of belinostat (PXD101) in combination with carboplatin and paclitaxel (BelCaP) for patients (pts) with transitional cell carcinoma (TCC) of the bladder
J. Barriuso, G. Daugaard, S. Frentzas, L. Fuglsang, R. Glasspool, A. Krarup-Hansen, R.J. Jones, U. Lassen, L. Sengeløv, J.S. De BonoVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72145-1
File:
PDF, 72 KB
english, 2008